Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 17 of about 17 for Genentech Inc.�
Company Exchange Symbol Last price Quote change Market cap
PDL BioPharma Inc NASDAQ PDLI 6.66 1.09B
PDL BioPharma, Inc. (PDL) is a biotech company. The Company is engaged in managing a portfolio of patents and royalty assets, consisting primarily of its ...
Biogen Inc NASDAQ BIIB 398.68 93.78B
Biogen Inc., formerly Biogen Idec Inc., is a global biotechnology company. The Company discovers, develops, manufactures and markets therapies for the ...
ImmunoGen, Inc. NASDAQ IMGN 8.89 766.19M
ImmunoGen, Inc. is a biotechnology company. The Company develops targeted anticancer therapeutics. The Company has three wholly-owned product candidates in ...
Genentech, Inc. Private
... human growth hormone Nutropin, cystic fibrosis drug Pulmozyme, and asthma drug Xolair. Genentech is wholly owned by Swiss pharma powerhouse Roche.
Array Biopharma Inc NASDAQ ARRY 7.52 1.06B
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients ...
Exelixis, Inc. NASDAQ EXEL 3.15 617.15M
Exelixis, Inc., is a biotechnology company. The Company is engaged in developing small molecule therapies for the treatment of cancer.
Roche Holding AG ETR RHO5 106.90 -0.45 (-0.42%) 0.00
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
Aptose Biosciences Inc NASDAQ APTO 5.95 72.60M
Aptose Biosciences Inc is a clinical-stage biotechnology company. The Company is engaged in discovering and developing personalized therapies addressing ...
PDL BIOPHARMA INC. DL-,01 FRA PDL 6.04 +0.21 (3.53%)
Xenon Pharmaceuticals Inc NASDAQ XENE 12.59 179.14M
(Teva) (through its subsidiary, Ivax International GmbH), Genentech, Inc. ( Genentech), and Merck & Co., Inc. (Merck) (through its affiliate, Essex Chemie ...
Aptose Biosciences Inc TSE APS 7.54 +0.09 (1.21%) 89.62M
Aptose Biosciences Inc is a clinical-stage biotechnology company. The Company is engaged in discovering and developing personalized therapies addressing ...
BIOGEN INC. DL -,0005 FRA IDP 364.20 +3.78 (1.05%)
BIOGEN INC. DL -,0005 ETR IDP 362.80 +3.25 (0.90%)
IMMUNOGEN INC. DL-,01 FRA IMU 7.84 +0.09 (1.13%)
EXELIXIS INC. DL-,01 FRA EX9 2.76 -0.02 (-0.72%)
EXELIXIS INC. DL-,01 ETR EX9 0.0000
XENON PHARMACEUTICALS FRA XP0 11.08 +0.21 (1.95%)